GE Healthcare launched this week its Amersham Hyperfilm Blue film for the detection of chemiluminescent signals in various blotting assays.
According to the company, the new film offers lower sensitivity than Amersham Hyperfilm, enabling researchers to produce faster qualitative results in Western, Southern, and Northern blots, reducing minimal exposure time to as little as one minute.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
